Peripheral and mesencephalic transfer of a synthetic gene for the thymic peptide thymulin

Brain Research Bulletin

Volumn 69, Issue 6, 2006, Pages 647-651

  Morel, Gustavo R ^a   Brown, Oscar A ^a   Reggiani, Paula C ^a   Hereñú, Claudia B ^a   Portiansky, Enrique L ^b   Zuccolilli, Gustavo O ^b   Pléau, Jean M ^c   Dardenne, Mireille ^c   Goya, Rodolfo G ^a  

^a INSTITUTO DE INVESTIGACIONES BIOQUÍMICAS DE LA PLATA INIBIOLP   (Argentina)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^c CNRS   (France)

Author keywords

Adenoviral vector; Antiinflammatory action; Gene transfer; Long term expression; Substantia nigra; Synthetic gene; Thymulin

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; FACTEUR THYMIQUE SERIQUE; GREEN FLUORESCENT PROTEIN; SYNTHETIC DNA; THYMIDINE KINASE; THYMULIN; THYMUS PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; BRAIN METABOLISM; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HISTOCHEMISTRY; HORMONE BLOOD LEVEL; MALE; MESENCEPHALON; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPORTER GENE; SUBSTANTIA NIGRA; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; DIAGNOSTIC IMAGING; FEMALE; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENES, SYNTHETIC; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; THYMECTOMY; THYMIC FACTOR, CIRCULATING; TIME FACTORS;

EID: 33646578169     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2006.03.015     Document Type: Article

References (19)

1. Bach J.F. Thymulin (FTS-Zn). Clin. Immunol. Allergy 3 (1983) 133-156
2. Bach J.F., Dardenne M., and Goldstein A.L. Clinical aspects of thymulin (FTS). In: Goldstein A.L. (Ed). Thymic Hormones and Lymphokines. Basic Chemistry and Clinical Applications (1984), Plenum Press, New York 593-600
3. Bach J.F., Dardenne M., Pléau J.M., and Rosa J. Biochemical characterization of a serum thymic factor. Nature 266 (1977) 55-57
4. Castaño A., Herrera A.J., Cano J., and Machado A. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J. Neurochem. 70 (1998) 1584-1592
5. Dardenne M., and Bach J.F. The sheep cell rosette assay for the evaluation of thymic hormones. In: Van Bekkum D.W., and Kruisbeek A.M. (Eds). Biological Activity of Thymic. Hormones. International Workshop and Symposium (1975), Kooyker Scientific Publications/Halsted Press Division/Wiley, Rotterdam, The Netherlands 235-243
6. Dardenne M., Pleau J.M., Nabarra B., Lefrancier P., Derrien M., Choay J., and Bach J.F. Contribution of zinc and other metals to the biological activity of serum thymic factor (FTS). Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 5370-5373
7. Folch J., Lees M., and Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-509
8. Gastinel L.N., Dardenne M., Pléau J.M., and Bach J.F. Studies on the zinc-binding site to the serum thymic factor. Biochim. Biophys. Acta 797 (1984) 147-155
9. Goya R.G., Console G.M., Herenu C.B., Brown O.A., and Rimoldi O.J. Thymus and aging: potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models. Gerontology 48 (2002) 325-328
10. Hitt M., Bett A., Prevec L., and Graham F.L. Construction and propagation of human adenovirus vectors. In: Celis J. (Ed). Cell Biology: A Laboratory Handbook (1998), Academic Press, New York 1500-1512
11. Marshall D.J., and Leiden J.M. Recent advances in skeletal-muscle-based gene therapy. Curr. Opin. Genet. Dev. 8 (1998) 360-365
12. McGeer P.L., and McGeer E.G. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat. Disord. 10 Suppl. 1 (2004) S3-S7
13. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, San Diego
14. P.C. Reggiani, C.B. Hereñú, O.J. Rimoldi, O.A. Brown, J.M. Pléau, M. Dardenne, R.G. Goya, Gene therapy for long-term restoration of circulating thymulin in thymectomized mice and rats. Gene Ther. (2006) in press.
15. Rivera V.M., Ye X., Courage N.L., Sachar J., Cerasoli Jr. F., Wilson J.M., and Gilman M. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 8657-8662
16. Safieh-Garabedian B., Dardenne M., Pleau J.M., and Saade N.E. Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat. Br. J. Pharmacol. 136 (2002) 947-955
17. Safieh-Garabedian B., Kendall M.D., Khamashta M.A., and Hughes G.R.V. Thymulin and its role in immunomodulation. J. Autoimmunity 5 (1992) 547-555
18. Safieh-Garabedian B., Ochoa-Chaar C.I., Poole S., Massaad C.A., Atweh S.F., Jabbur S.J., and Saadé N.E. Thymulin reverses inflammatory hyperalgesia and modulates the increased concentration of proinflammatory cytokines induced by i.c.v. endotoxin injection. Neuroscience 121 (2003) 865-873
19. Stone D., Xiong W., Williams J.C., David A., Lowenstein P.R., and Castro M.G. Adenovirus expression of IL-1 and NF-kappaB inhibitors does not inhibit acute adenoviral-induced brain inflammation, but delays immune system-mediated elimination of transgene expression. Mol. Ther. 8 (2003) 400-411